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Abstract
Streptococcus pneumoniae of serotype 3 possess a mucoid capsule and cause disease associated with high mortality rates
relative to other pneumococci. Phylogenetic analysis of a complete reference genome and 81 draft sequences from clonal
complex 180, the predominant serotype 3 clone in much of the world, found most sampled isolates belonged to a clade
affected by few diversifying recombinations. However, other isolates indicate significant genetic variation has accumulated
over the clonal complex’s entire history. Two closely related genomes, one from the blood and another from the
cerebrospinal fluid, were obtained from a patient with meningitis. The pair differed in their behaviour in a mouse model of
disease and in their susceptibility to antimicrobials, with at least some of these changes attributable to a mutation that up-
regulated the patAB efflux pump. This indicates clinically important phenotypic variation can accumulate rapidly through
small alterations to the genotype.
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Introduction
Streptococcus pneumoniae is a human nasopharyngeal commen-
sal and respiratory pathogen responsible for a high burden of
morbidity and mortality worldwide. Serotype 3 was one of the
earliest pneumococcal capsule types to be identified [1]. For
some time, there was dispute over whether these bacteria
should be considered a separate species, named Streptococcus or
Pneumococcus mucosus [2], and whilst such a separation cannot
be justified on the basis of genetic divergence it does have
distinctive morphological and epidemiological traits. Bacterial
colonies of this serotype have a characteristic mucoid
phenotype when grown on agar, as the cellobiuronic acid
polymeric chains of the capsule are not covalently attached to
the cell wall [3,4]. Unusually for S. pneumoniae, the risk of
serotype 3 disease increases with age [5–8], which may relate
to the high immunogenicity of the capsule antigen in young
children [9].
Importantly, disease caused by this serotype has been consis-
tently associated with a high relative risk of mortality in humans
[5,6,10–13], and correspondingly strains of this serotype are
amongst the quickest to cause death in a mouse model of
bacteraemia [14]. The high level of mortality may stem from the
high frequency with which serotype 3 isolates cause extrapulmo-
nary manifestations of pneumococcal infection [15], with evidence
that the serotype is associated with causing brain abscesses [16–
18]. Whether these characteristics are the consequence of the
capsule or the genetic background itself is difficult to study,
because few genotypes are stably associated with the type 3
capsule.
The most common of these in the multilocus sequence type
database [19] is represented by isolates of, or closely related to,
sequence type 180 (ST180); this lineage is therefore termed clonal
complex 180 (CC180), or the Netherlands 3–31 (PMEN31) clone
[20]. This lineage is geographically highly widespread, having
been found across Europe [21], Japan [22] and North and South
PLOS Genetics | www.plosgenetics.org 1 October 2013 | Volume 9 | Issue 10 | e1003868
America [21,23–25]. Although it is not associated with penicillin
resistance, macrolide resistant representatives of the genotype have
been identified [22]. Since 2001, this lineage has been observed to
increase in prevalence among invasive disease isolates from the
USA following the introduction of the heptavalent conjugate
vaccine, which does not protect against serotype 3 pneumococci
[23]. Higher valency anti-pneumococcal conjugate polysaccharide
vaccine formulations targeting this capsule, such as the recently
introduced 13-valent vaccine, appear to trigger only weak immune
reactions to their serotype 3 components, hence it remains unclear
how effective they will be against such pneumococci [26,27].
Therefore to better characterise this unusual and important
lineage, a complete reference genome was generated and
compared to sequence data from 81 other representatives.
Results
Whole genome phylogeny of clonal complex 180
The complete genome of S. pneumoniae OXC141, a serotype 3
ST180 carriage isolate from a child in Oxford, was generated
using a combination of 454 and capillary sequence data. The
chromosome was found to be 2,036,867 bp long and contained
1,986 coding sequences (CDSs; including 153 pseudogenes),
alongside many small interspersed repeat elements: 122 BOX
elements, 106 RUP elements and 29 SPRITE repeats [28]. Two
putative mobile genetic elements could be identified: the 34 kb
prophage wOXC141 [29] and a 6.3 kb island likely to be related
to, or derived from, an integrative and conjugative element (ICE)
[30]. Two further large, distinctive gene clusters were also evident:
a ,22 kb region directly upstream of pspA appearing to encode
multiple bacteriocin production systems, and the variable region of
Pneumococcal Pathogenicity Island 1 (PPI-1) containing a ,25 kb
long set of miscellaneous metabolic genes [31].
In order to ascertain the level of variation in gene content across
CC180, comparative genomic hybridisation was used to select six
further representatives to be sequenced using a combination of
454 and capillary technologies. These were complemented by an
international sample of 75 isolates from Europe and North
America sequenced as multiplexed libraries using the Illumina
GAII platform (Table S1). A phylogenetic analysis of this
collection was performed as described previously [32].
A total of 12,605 substitutions were reconstructed as occurring
over the history of the lineage, of which 77% were introduced by
82 recombinations (two acquisitions of prophage, one recombina-
tion affecting the ICE-related sequence and 79 putative homol-
ogous recombinations; Figure 1). The lengths of the homologous
recombinations were exponentially distributed with a mean length
of 11.5 kb (Figure S1), each introducing a mean of 116
substitutions. However, a highly irregular pattern of sequence
imports is clear across the phylogeny, with the majority of the
variation arising on a small number of long branches separating
three clades (labelled I, II and III in Figure 1). Single nucleotide
polymorphisms (SNPs) were detected at just 1,925 sites in clade I,
which contains all but six isolates. Only one prophage integration,
and eleven putative homologous recombinations of a mean length
of 20.4 bp, are detected in this clade, resulting in an overall per
site r/m (the ratio of substitutions accumulating through recom-
bination relative to those occurring through point mutation) of
0.07, approximately two orders of magnitude below the equivalent
value of 7.2 calculated for the PMEN1 lineage using the same
method [32]. This absence of any signs of extensive sequence
import into clade I through homologous recombination was
confirmed by analysing the whole genome alignment with
BRATnextgen (Figure S2) [33].
The tree structure suggests clade I is an expansion emerging
from a more diverse background of isolates, although the
geographic bias of the sample makes it difficult to draw general
demographic conclusions. Hence the apparent absence of
widespread recombination may reflect a short evolutionary history
of clade I, in which there has been little time to horizontally
acquire novel sequence. However, a coalescent analysis of the
phylogeny indicated this clade is likely to have last shared a
common ancestor in about 1947 (95% credibility interval: 1907–
1970). The same analysis predicted an overall age of around 330
years (95% credibility interval: 592-177 years) for CC180. The
implied mean substitution rate of 3.6561027 substitutions per site
per year (95% credibility interval 1.7761027–5.5861027 substi-
tutions per site per year) is slower than that of PMEN1 (1.5761026
substitutions per site per year), which may be the consequence of
purifying selection having more time to remove deleterious
substitutions in this older lineage [34]. Nevertheless, it appears
clade I is of at least an equivalent age, and very likely older, than
the multidrug-resistant lineages in which extensive horizontal
sequence transfer has been observed, leading to the impression
that the genotype has been effectively ‘frozen’ over decades.
Extensive variation in the accessory genome
Identification of variable loci through comparison of de novo
assemblies revealed extensive overall variation contrasting with
stability within clade I, in agreement with the phylogeny (Figure 2).
For instance, the widespread presence of prophage wOXC141
indicates it was acquired by an ancestor of clade I and
subsequently deleted on at least seven independent occasions
based on this sample (Figure S3). This virus, observed to form
intact virions following induction with mitomycin C [29], appears
to be active during in vitro culture based on the sequence read
coverage compared to the rest of the genome (Figure S4). One of
the few genotypes to have lost wOXC141, BHN167, is the only
isolate in clade I showing evidence of having acquired a novel
prophage (wBHN167), which is highly divergent from the others in
the collection. Nevertheless, the level of flux of such elements
appears much slower than observed in PMEN1 [32].
Author Summary
Streptococcus pneumoniae (‘the pneumococcus’) is a
bacterium commonly found asymptomatically in the
human nasopharynx that represents a common cause of
diseases such as pneumonia, bacteraemia and meningitis.
Some strains have been found to exchange DNA with
other bacteria at a high rate. However, serotype 3
pneumococci are unusual both in not exhibiting much
genetic variation and causing disease with a comparatively
high relative rate of mortality. Here we used whole
genome sequencing to characterise 82 serotype 3 pneu-
mococci, finding that the majority of the population
accumulate variation very slowly. However, comparing two
isolates from a single case of disease revealed a small
number of mutations had occurred over a short period of
time. These resulted in differences in the activity of several
genes, including two encoding a drug efflux pump. The
pair of isolates was found to differ in their tolerance of
different antimicrobial compounds and their behaviour in
a mouse model of disease. However, moving the mutation
that caused the change in resistance into a distantly-
related pneumococcus failed to fully replicate the other
changes in behaviour, which indicates that interpretation
of the impact of mutations in different strains of diverse
bacterial species will be difficult.
Evolution of Serotype 3 Pneumococci
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Also stable within clade I are the proteinaceous antigens PspA
and PspC (Figure 2), which are highly variable across the species
[35,36]; however, divergent alleles are evident in the other CC180
clades. Similarly, loci encoding putative bacteriocin synthesis gene
clusters differ between the annotated clades, with the large island
upstream of pspA varying even within clade I: one deletion of
approximately 10 kb, seemingly driven by a recombination
between the very similar regulatory genes SPNOXC01360 and
SPNOXC01480, is homoplasic within the sample. Metabolic
operons, by contrast, only exhibited considerable between-clade
variation. This suggests accessory loci are gained over the long
periods of divergence separating clades, with subsequent occa-
sional deletion observed over shorter timescales, although only
clade I is sampled with sufficient density to study this pattern in
detail.
Just one instance of antibiotic gene acquisition is evident in the
collection. This is an insertion of a Tn916-type element [37],
carrying the tetM tetracycline resistance gene, into the Bolivian
strain S. pneumoniae 07-2838. Furthermore, no fluoroquinolone
resistance polymorphisms within the topoisomerase genes gyrA,
gyrB, parC and parE could be found, despite being homoplasic in
the phylogenies of such disparate genotypes as S. pneumoniae
PMEN1 [32], Staphylococcus aureus ST239 [38] and Salmonella Typhi
[39]. These can arise spontaneously through point mutation, and
therefore seemed likely to be observed even in cases where
recombination is not common.
Within-patient variation of pneumococci
However, there is one SNP in the phylogeny associated with
antibiotic resistance: a polymorphism 46 bp upstream of the start
codon of the genes encoding the ABC-type efflux pump PatAB
[40] distinguishing the closely-related clade I isolates S. pneumoniae
99-4038 and 99-4039. These were cultured from a single patient
with meningitis: 4038 was taken from the bloodstream, and 4039
from the cerebrospinal fluid (CSF). They were selected for
sequencing from a screen of isolate pairs, each obtained from
the same patient, owing to them exhibiting the most pronounced
difference in transcriptional profiles. Improved high quality draft
Figure 1. Phylogenetic analysis of the clonal complex 180 isolates. (A) A simplified representation of the 2,036,867 bp genome of S.
pneumoniae OXC141 with tick marks every 0.5 Mb. The loci encoding the proteinaceous antigens PspA and PspC, as well as the capsule biosynthesis
locus, are labelled, as are the prophage QOXC141, a putative ICE-related sequence, the ,22 kb bacteriocin island and Pneumococcal Pathogenicity
Island 1 (PPI-1). (B) A maximum likelihood phylogeny of the serotype 3 isolates based on the vertically inherited substitutions not introduced through
recombination events. The tree and taxa are coloured according to their geographical location. (C) The panel surrounded by the dotted line contains
one row for each isolate in the tree, with a column for each base in the reference genome. Red blocks indicate recombination events reconstructed as
occurring on an internal branch, hence are shared by more than one isolate through common descent, while blue blocks indicate recombinations
unique to one particular isolate.
doi:10.1371/journal.pgen.1003868.g001
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genomes of both isolates revealed a small number of polymor-
phisms largely concentrated in repetitive or hypervariable regions
of the chromosome that likely represent difficulties in assembly or
mutation during in vitro culture (Table S2). Nevertheless, three
high-confidence mutations can be identified as distinguishing the
pair in addition to the base substitution upstream of patAB: a
synonymous change in the putative regulatory protein
SP4038_08190, a non-synonymous L227M substitution in the
putative hydrolase SP4038_11450, and a frameshift mutation
truncating the putative phosphohydrolase SP4038_15170 in 4038.
The first test of whether these two isolates from distinct
anatomical sites differed in their transcriptional profiles had
involved hybridising RNA samples extracted from 4038 and 4039
during in vitro growth to a microarray based on the genomes of S.
pneumoniae TIGR4 and R6. This revealed the significant differences
in their patterns of gene expression detailed in Table S3. The
patAB genes were found to be approximately five-fold upregulated
in 4039, while the RNA polymerase gene rpoE and translation
machinery genes rplS, rpsB and tsf were each expressed at a lower
level. RNA sequencing (RNA-seq) of three further independent
paired samples from the two isolates grown to an OD600 of 0.6 in
Brain-Heart infusion were then used to characterise these
differences more precisely. This experiment confirmed the results
for the previously mentioned genes, with patAB this time exhibiting
approximately four-fold greater transcription in 4039 (Table S4).
The change in expression appeared to coincide with the SNP
Figure 2. Distribution of accessory genome loci. (A) The non-prophage accessory genome loci, identified through comparison of genome
assemblies, are displayed as blocks of alternating colours. The loci are coloured and grouped according to their functional annotation. All sequences
are labelled with their position in a publicly available genome, or their ENA accession code; some have been trimmed to remove insertion sequences,
to avoid read mapping artefacts. (B) The maximum likelihood phylogeny, as displayed in Figure 1. (C) This panel is composed of one row per taxon,
each representing the output of mapping the sequence reads from an individual sample against the accessory genome loci. This is displayed as a
heatmap that is blue where there is no read mapping, indicating an absence of a locus, changing to red where there is read mapping indicating the
locus is present (scaled to a maximum of 100 reads per million reads mapped).
doi:10.1371/journal.pgen.1003868.g002
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distinguishing the isolates (the allele of this locus found in 4039 is
henceforth referred to as the patAB upstream SNP, PUS; Figure 3),
with both genes co-transcribed as an operon despite the
intervening degenerate transposase sequence being encoded on
the complementary strand of the genome.
Overall, RNA-seq found 54 CDSs differed significantly in their
level of expression between the two isolates, grouped into 11 gene
clusters and 18 singleton CDSs based on the genome sequences.
The chaperone genes dnaK, grpE and clpL were found to be
transcribed at a lower level in 4039. By contrast, many genes
involved in nucleotide biosynthesis and acquisition exhibited
higher levels of expression in 4039. These include many genes in
the pur operon, the adenylate kinase adk, the guanine monophos-
phate synthase guaA and the putative xanthine or uracil transporter
SP4038_03000.
Patterns of gene expression
The RNA-seq data also provided information on the expression
of some of the distinctive genetic loci associated with CC180
genome sequences. Congruent with the DNA sequence coverage
mapping, active transcription of the wOXC141 prophage’s lytic
cycle genes was observed (Figure S4), although transcription of the
Figure 3. Expression of the patAB locus. (A) Annotation of the patAB gene cluster, with the intervening IS element remnant on the opposite
strand, and the upstream mutS gene. The position of the C1855761A polymorphism distinguishing S. pneumoniae 4038 and 4039 is indicated. (B)
Graph showing Illumina read coverage, standardised as a plot of reads mapping per million reads mapped, from RNA-seq experiments. Each line
shows the mean value from three replicates surrounded by a shaded area representing the minimum and maximum values. The red and orange lines
represent transcription of the two strands of the genome in 4038, and the blue and green lines represent the transcription of the two strands of the
genome in 4039.
doi:10.1371/journal.pgen.1003868.g003
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lysogeny module was also apparent, indicating a mixed population
with active phage replication in some cells. Overall, there was no
evidence of discrete states of transcription (Figure S5), consistent
with studies in other species [41]. When categorised according to
gene function, it is clear the most highly expressed genes, in a sense
direction, are those involved in glycolysis, central metabolism,
transcription and translation (Figure S6). By contrast, those CDSs
associated with the highest levels of antisense transcription relative
to sense activity were pseudogenes (Figure S7), with a significantly
higher proportion of these gene fragments transcribed in a
predominately antisense direction in comparison to intact CDSs
(Fisher’s exact test, p value = 6.14610211). This indicates a level of
decay of transcriptional regulation of such loci in the chromosome,
with the degenerate IS element in the patAB operon a clear
example (Figure 3).
There are also two notable examples of functional operons
being highly expressed in an antisense manner. One is a gene
cluster encoding a series of restriction endonuclease system genes
(SP4038_07830-07890). Another is the comCDE operon, encoding
the competence stimulating peptide precursor and its cognate
receptor. Antisense transcription of these genes, crucial for
activating the competence system for DNA uptake, contrasts with
their predominately sense transcription in a sample extracted from
the PMEN1 isolate S. pneumoniae ATCC 700669 under similar
conditions [42]. Such regulation may indicate one reason that so
few transformation events are observed in clade I of CC180. Few
other reasons are obvious from the genome sequences alone, with
the major elements of the competence machinery appearing intact
in all isolates with the exception of the isolates BHN644, BHN587
and BHN605, with premature stop codons detected in the comD
sensor kinase, comFA helicase and comEA transport system,
respectively.
Variation in resistance and virulence
The PUS is the polymorphism likely to be making the biggest
contribution to the observed changes in transcription, as it is
closely linked to the genes undergoing the greatest change in
expression, patAB. This locus has previously found to vary in
activity between clinical isolates [43] both in the presence and
absence of inducing chemicals such as fluoroquinolones and
mitomycin C [44]. Therefore it seems likely these genes are likely
to be subject to altered selective pressures during the progression of
disease. The impact of the other polymorphisms differentiating
4038 and 4039 is more difficult to understand. The substitution in
the putative regulatory gene is synonymous, and therefore unlikely
to contribute to alterations in expression. Ascertaining the effect of
the polymorphisms in phosphohydrolases is difficult given the
unknown impact of the changes on gene products with functions
that have yet to be thoroughly characterised.
Isolates with elevated levels of patAB expression are observed to
have reduced susceptibility to fluoroquinolones and other antimi-
crobials, including linezolid [40], reserpine [45], acriflavine,
berberine, ethidium bromide [46] and the dye Hoescht 33352
[43]. The sensitivity of isolates 4038 and 4039 to a wide range of
antimicrobial compounds and osmolytes at a range of concentra-
tions was therefore tested using phenotype microarrays [47]. A
significant difference between the isolates could be detected in 25
cases; all resulted from S. pneumoniae 4039 exhibiting greater
resistance to antimicrobial agents (Table S5), with no evidence that
increased expression of patAB affected the bacterium’s membrane
integrity based on the sensitivity to concentration gradients of
osmolytes. Isolate 4039 appeared to exhibit higher levels of
tolerance of the toxic anions boric acid, sodium metaborate and
sodium bromide, which could indicate elevated efflux pump
activity. Other antimicrobials that resulted in 4039 having a
significantly elevated respiratory rate relative to 4038 were, like
fluoroquinolones, nucleic acid intercalators: proflavine and the
related compound acriflavine, along with 5,7-dichloro-8-hydro-
xyquinoline and 6-mercaptopurine, for which a significant
difference was observed at three of the four tested concentrations.
Some of the other compounds identified as distinguishing the
isolates, such as pentachlorophenol, crystal violet and 2,4-
dinitrophenol, are known to act as uncouplers of proton gradients.
This could be the consequence of such compounds being removed
from the cell by the PatAB efflux pump or, as PatAB is an ABC
transporter and therefore not dependent on electrochemical
gradients as some other pumps are, this difference in respiration
rate may represent a more general change in the overall pattern of
molecule efflux. In conjunction with the previously reported
elevated resistance to a variety of compounds, these data indicate
elevated PatAB activity is likely to increase tolerance to a broad
spectrum of antimicrobials.
To test whether these phenotypic alterations impacted on the
virulence of the two isolates, both were assayed in the mouse
model of invasive pneumococcal disease (Figure 4). When 102
colony forming units (CFU) were introduced through intraperito-
neal inoculation there was no significant difference in the survival
time in animals infected with either isolate. However, animals
infected with 4038 had 1010 CFU/mL in the blood at the time of
death whereas animals infected with 4039 had very low bacterial
counts in the bloodstream. When the intraperitoneal challenge
dose was increased to 104 CFU all animals infected with 4039
reached the end point by 24 h, whereas those infected with 4038
lasted until 42 h (Wilcoxon test, n = 4, p=0.0082), although in this
experiment there were no significant differences in the organ
distribution of the isolates. When a model of pneumonia was
induced by intranasally inoculating animals with 106 CFU there
was no difference in survival time in animals infected with either
isolate. However mice infected with strain 4039 developed higher
levels of bacteraemia earlier in the infection with significantly
higher levels in the blood after 24 and 48 h post infection; 4039
was also present in significantly higher numbers in the nasophar-
ynx and brain relative to 4038. Hence the observed significant
differences in tissue distribution of each genotype were heavily
dependent upon the route of inoculation.
Complex consequences of patAB regulatory changes
Analysis of the region upstream of the patAB operon revealed
promoter motifs close to the consensus sequences appearing to
initiate transcription 67 nt upstream of the patA start codon. The
consequent 59 untranslated region is predicted to fold into a
bulged hairpin loop followed by a run of uridine residues,
indicating it could function as a terminator (Figure 5). This
suggests a simple transcriptional attenuation regulatory mecha-
nism: any signal that destabilizes this hairpin seems likely to
increase the transcription of the downstream CDSs. The
transcription of these genes is known to be increased by
compounds that can intercalate nucleic acids, which have been
found to induce conformational changes in bulged RNA hairpin
loops [48]. Whether regulation is via such a direct interaction, or
involves other factors, it would seem appropriate that patAB would
be induced through a relatively non-specific signal given its
apparent ability to remove a range of intercalating compounds
from the cell.
The PUS distinguishing 4038 and 4039 is predicted to
destabilize this hairpin loop (Figure 5), likely reducing any
transcriptional attenuation and providing a potential explanation
for the observed difference in expression levels. To study the
Evolution of Serotype 3 Pneumococci
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consequences of this SNP in isolation, the genetically tractable S.
pneumoniae TIGR4 strain [49], which has the same sequence
upstream of patAB as 4038, was transformed with the region
upstream of patA from isolates 4038 and 4039. Isolation of
fluoroquinolone resistant colonies that had acquired the PUS from
4039 (Figure S8), followed by characterisation with E tests,
indicated the PUS increased the ciprofloxacin MIC from
1 mg L21 to 4 mg L21, while the MICs of 4038 and 4039 were
0.75 mg L21 and 2 mg L21, respectively (Table S6). Hence the
PUS elevates resistance in both backgrounds, with the MIC also
being determined by the rest of the isolate’s genotype.
Comparing the expression profile of S. pneumoniae TIGR4 and
TIGR4PUS using a microarray revealed the patAB operon was
upregulated by a relatively small degree, (,2.5 fold) with no
evidence of other significant differences, such as those observed
between 4038 and 4039 (Table S7). Furthermore, comparison of
TIGR4 and TIGR4PUS using the mouse model of disease found
no significant difference in the rate at which the mice reached the
end point of infection, nor the final tissue distribution of bacteria
(Figure S9).
Discussion
The patterns of evolution observed across this collection of
CC180 isolates can be seen as reflecting the impact of selection on
accumulated variation over different timescales. Polymorphisms
are acquired horizontally at a heterogeneous rate across the tree,
with deep branching clades distinguished by extensive sequence
diversity arising through point mutation, transformation and the
movement of mobile genetic elements. Within clade I, however,
horizontal sequence transfer makes almost no contribution to the
evolution of the genotype, which is ‘frozen’ in a stable form.
Whether this sample, with its geographical bias towards Europe,
reflects the overall population structure of CC180 is unclear;
denser sampling of clades II and III samples may indicate the
recombinations occurred gradually in these lineages, with clade I
being atypically stable. Nevertheless, as the number of point
mutations in clade I indicates it has been diverging over decades, it
remains clear that transformation events are accumulating at a
very low rate in this lineage.
Contrasting with this slow overall net rate of diversification, four
high-confidence polymorphisms could be identified distinguishing
the isolates 4038 and 4039 from a single patient. These mutations
(the PUS, a synonymous change in a DNA-binding protein, a non-
synonymous substitution in one putative hydrolase and a
truncation of another) may well represent normal neutral
diversification that is purged by purifying selection, or lost by
drift, over longer timescales. Alternatively, they may be the
product of adaption to the change in environment encountered
during the course of invasive pneumococcal disease. The latter
Figure 4. Differences in virulence of S. pneumoniae 4038 and 4039, clinical isolates in which the latter contains a SNP upregulating
patAB. The results of three experiments are shown: (A) mice inoculated with 102 CFU intraperitoneally (n = 5), (B) mice inoculated with 104 CFU
intraperitoneally (n = 5) and (C) mice challenged with 106 CFU intranasally (n = 5). For each, the displayed outcomes are: (i) survival curves, (ii) level of
bacteraemia and (iii) counts of the two isolates in different organs. Significant differences between viable cell counts, calculated at a p,0.05 level
using a T test, are indicated by asterisks.
doi:10.1371/journal.pgen.1003868.g004
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scenario seems most likely in the case of the PUS, based on the
diversity in patAB expression observed in surveys of clinical isolates,
and a previous observation of resistance emerging during serotype
3 pneumococcal disease (although the underlying mechanism of
resistance, and genetic background of the strain, are not known
[50]). However, only with more detailed characterisation of
within-host evolution in different anatomical niches will be
possible to systematically answer this question. Such studies are
beginning to be performed: for instance, mutations have been
observed to accumulate over short timescales during carriage and
disease caused by Staphylococcus aureus [51,52], and Escherichia coli
[53,54], with some of the observed changes associated with
differences in mouse models of virulence.
The alternative explanation to adaptation, that these SNPs
represent neutral mutation that does not persist over longer
timescales, would suggest that purifying selection might contribute
Figure 5. Leader sequence upstream of patAB. The graph represents the free energy of the most stable folded form of the 59 region of the
patAB transcript, as it extends from the promoter, in 4038 (black line) and 4039 (red line). The positions of the C1855761A polymorphism (PUS)
distinguishing the two isolates and translation initiation site are indicated by the dashed lines, while the Shine-Dalgarno sequence is represented by
the shaded region. The terminator-like hairpin structures formed by both transcripts as the RNA reaches the point at which the Shine-Dalgarno
sequence is transcribed are displayed; it is evident that the mutation in 4039 is predicted to greatly weaken the hairpin loop of this secondary
structure.
doi:10.1371/journal.pgen.1003868.g005
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to maintaining the antibiotic sensitive phenotype. However, lack of
resistance to other antibiotics may also be attributable to the
inability to acquire the requisite sequences. For instance, the
Tn916-type tetracycline resistance element observed in one isolate
indicates it is possible for the genotype to acquire ICEs; the rarity
of this resistance in CC180 may just represent such transfers being
infrequent, or it may be that selection is the more important factor
in eliminating isolates with such transposons. Perhaps the most
interesting case is the absence of any large recombination events in
clade I having precluded the development of b-lactam resistance
through modification of penicillin binding proteins. Given the
hypothesised ‘purging’ of point mutations through selection
suggested by the relative rates of base substitution during disease
and over the phylogeny, the ‘frozen’ genotype could be the
consequence of recombination events being similarly removed by
selection in CC180. Alternatively, it may simply be that CC180
imports DNA at a low rate relative to other pneumococci,
resulting in the stalling of clade I’s diversification. Reasons behind
CC180’s lack of transformation could be the consequence of
inhibition by the mucoid capsule; this has been observed to slow,
but not entirely inhibit, transformation in non-CC180 serotype 3
pneumococci [55]. Another physiological explanation for a slowed
rate of DNA uptake could be the antisense transcription of the
competence-inducing comCDE genes, if this were also observed to
occur in vivo. Alternatively, the explanation could reflect the
lineage’s epidemiology. Serotype 3’s increased prevalence in adults
(inferred from disease frequency; e.g. [5]) may mean it has
relatively little opportunity to import sequence diversity owing to
the reduced chance of co-colonising with most other genotypes,
which are found more frequently in children.
Nevertheless, diversification through point mutations alone can
still result in large phenotypic differences, as demonstrated by the
behaviour of isolates 4038 and 4039 in the mouse model of
disease. Following intraperitoneal inoculation, 4038 caused high-
level bacteraemia, whereas 4039 was cleared from the blood-
stream; this is interesting given the isolation of 4038 from the
blood of the patient. By contrast, 4039 rises faster in the blood
following intranasal inoculation, and is found at higher levels in
the brain, perhaps suggesting an enhanced ability to traverse
anatomical barriers could explain its presence in the CSF of the
original patient. Hence polymorphisms distinguishing the pair may
represent adaptation to different anatomical niches over a short
timescale.
One potential explanation of this multiplicity of phenotypic
differences between 4038 and 4039 is that they all represent
consequences of the PUS. This would suggest the PUS is likely to
be atypical in having such a strong impact on phenotype, owing to
its effects on the regulation of a broad-spectrum pump induced by
a wide range of compounds. However, such a hypothesis must also
account for the failure of the SNP to cause the same changes in the
TIGR4 strain, perhaps owing to genetic interactions with other
loci modulate the impact of the mutation. The baseline differences
in fluoroquinolone susceptibility between TIGR4 and 4038
provide some evidence for this. Hence further work investigating
the activity of the PatAB pump in different backgrounds seems
likely to be informative. Recent characterisation of a patAB
knockout mutant of the S. pneumoniae R6 strain using a phenotype
microarray found the mutant to have increased susceptibility to
fluoroquinolones and acriflavine, consistent with the phenotype
microarray work in this study, as well as tetracyclines, consistent
with the results of the Vitek 2 analysis (Table S6). Although
overlapping, the results were not entirely consistent [56], which
could represent the consequences of the contrasting genetic
manipulations of overexpression versus removal of the encoding
genes, differences in analytic approaches, or the influence of
genetic background upon the consequences of a polymorphism.
Combining the data in this study suggests that the PUS has an
unusually strong impact on phenotype in the CC180 background
in particular. It is notable that several of the transcriptional
changes observed in CC180, but not TIGR4, imply the PUS
causes dysregulation of purine metabolism. This could be a
consequence of metabolites involved in this pathway being
removed from the cell by the pump. Evidence for this hypothesis
is provided by the differences in respiration between 4038 and
4039 in the presence of the antimicrobial close purine analogue 6-
mercaptopurine. One putative reason why the CC180 genotype
might be unusually sensitive to such a perturbation of this aspect of
metabolism is that expression of the lysogeny module of
QOXC141 drives antisense transcription of the adjacent purA
gene, crucial for purine generation, in 4038 and 4039 (Figure S4).
Alternatively, one or more of the other polymorphisms
distinguishing 4038 and 4039 may cause the additional effects
the phenotypically differentiate this pair, but not TIGR4 and
TIGR4PUS. While the synonymous change in a regulatory protein
seems unlikely to have a large effect on measureable traits, the
observation of two mutations in phosphohydrolases could poten-
tially indicate selection for a particular alteration in cellular
biochemistry. Further investigation of cases of within-patient
evolution will be invaluable in highlighting whether any of these
SNPs are commonly identified occurring during the progression of
pneumococcal disease. Under such circumstances where more
than one of four observed polymorphisms were to measurably
affect the bacterial phenotype, it becomes difficult to make the
general assumption that the majority of observed polymorphisms
in the pneumococcal chromosome are selectively neutral. This
could be interpreted as supporting a role for purifying selection in
removing a high proportion of point mutations from the genotype,
congruent with the relative rates of mutation observed within the
patient and over the history of clade I. Ultimately, either
explanation – that the background into which the SNP is
introduced is important, or a high proportion of SNPs significantly
impact on the overall phenotype - indicate, even with whole
genome sequences, inferring the phenotypic consequences of even
small differences between strains will be a complex task.
Materials and Methods
Ethics statement
All animal work was approved by University of Glasgow ethics
committee and was conducted under National Guidelines under
Home Office Project Licence number 60/3703.
Genome sequencing
Seven isolates were selected for sequencing from an interna-
tional collection on the basis of the diversity of their accessory
genomes, as assayed through comparative genome hybridisation.
The reference genome of S. pneumoniae OXC141 was sequenced to
completion. For the assembly of the S. pneumoniae OXC141
genome, two shotgun libraries using the pSMART vector (insert
sizes 4–6 kb and 6–94 kb) and five shotgun libraries using the
pUC vector (insert sizes 0.8–1.2 kb, 1.2–2 kb, 1.2–1.6 kb, 2–
2.5 kb and 2–4 kb) were sequenced using BigDye terminator
chemistry on ABI3730 sequencing machines (Applied Biosciences)
Capillary sequence data were assembled using phrap2gap [57],
and multiple rounds of PCR used to close gaps and complete the
genome to a finished standard [58].
Isolates S. pneumoniae 99-4038, 99-4039, 02-1198, 03-4183, 03-
4156 and 07-2838 were sequenced to improved high quality draft
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status [58]. ABI3730 capillary sequence reads from shotgun
libraries cloned into pOTWI2 vectors were combined with 454
FLX sequence data to give hybrid assemblies using Newbler
(http://my454.com/products/analysis-software/index.asp) and
phrap2gap. Multiple rounds of PCR were used to close gaps.
For isolates S. pneumoniae 99-4038 and 99-4039, 75 nt paired end
Illumina sequence data (ENA accession codes: 4038, ERR052247;
4039, ERR052248) from multiplexed libraries sequenced on the
HiSeq platform were used to close gaps in the assembly with
IMAGE [59] and correct errors in the assembly using ICORN
[60]. All genomes reached improved high quality draft status [58].
Accessory genome components from strains sequenced only as
Illumina libraries were assembled using Velvet [61] as described
previously [32].
Genome annotation was based on a manually curated transfer
and extension of the annotation of S. pneumoniae ATCC 700669
[31] using Glimmer3 [62], Artemis and ACT [63].
All other isolates, representing an international collection from
Europe and the USA, were sequenced as multiplexed libraries
using the Illumina Genome Analyzer II as described previously
[32]. All isolates were sequenced to a mean depth of at least 55-
fold coverage.
All data have been submitted to the ENA nucleotide sequence
database with accession codes listed in Table S1.
Phylogenetic analysis
To produce the whole genome alignment, for those genomes
sequenced using a combination of 454 and capillary technologies,
Illumina read pairs of length and insert size the same as the other
taxa were simulated from the assembled contigs. Reads were
mapped to the reference genome using SMALT, and polymor-
phisms identified from the resulting alignment, as described
previously [64]. An iterative algorithm was used to identify
recombinations and generate a phylogeny as described previously
[32].
Analysis of the complete whole genome alignment was also
performed using BRATnextgen [33]. Based on the maximum
likelihood phylogeny’s structure, the number of groups was pre-
specified as four (clades I, II, III and isolate BHN609). A window
size of 1 kb was used and the alpha parameter was learned from
the analysis. The threshold for identifying recombinations was
exceeding a p value of 0.05 based on 100 permutations.
To test whether there was any sign of a molecular clock in the
data, for the clade I isolates for which a precise year of isolation
was available (n=66), this value was plotted against the root-to-tip
distance within the clade. This revealed a significant correlation
(R2 = 0.07, p value = 0.016; Figure S10) and suggested that clade I
originated around 1946. Therefore an analysis with BEAST [65]
was performed using the alignment of polymorphic sites, which
excludes substitutions introduced by putative recombination
events, associated with the fixed topology of the tree as displayed
in Figure 1. The dates of isolation listed in Table S1 were used to
estimate the phylodynamics with a relaxed lognormal mutation
rate [66], a skyline plot prior for demographic history [67] and a
GTR model of nucleotide substitution with a single rate category.
Phylogeographic analysis using discrete locations was conducted
using a continuous time Markov chain [68]. Ten chains of 100
million generations were used in the analysis; 50 million
generations of each were removed as burnin, and the remainder
of the data used to estimate the values described in the test. The
ESS values were above 200 for all outputs of the model. The
reported substitution rate represents the arithmetic mean of the
rate on each branch of the phylogeny.
Distribution of the accessory genome
The components of the accessory genome were manually
identified through comparisons using MUGSY [69] and ACT
[63]. To generate heatmaps, the Illumina sequence reads were
mapped against these accessory genome sequences using BWA
[70], then coverage plots were generated using Samtools [71].
Each sample’s plot was standardised according to the correspond-
ing number of reads mapped in the analysis to make them
comparable. Along with this general search for all accessory
genome loci, a search for sequence polymorphisms within genes
associated with resistance, specifically pbp1a, pbp2x, pbp2b, folP, dyr,
parC, parE, gyrA and gyrB, was conducted. This failed to identify any
variation that has been associated with antibiotic resistance.
Microarray experiments
Preparation and hybridisation of RNA samples to the BmG@S
SPv1.1.0 microarray were completed as described previously [72].
Three independent biological replicates were analyzed for each
isolate in the two comparisons (4038 against 4039, and TIGR4
against TIGR4PUS) using a common reference experimental
design. The BmG@S SPv1.1.0 array design is available in
BmG@Sbase (accession number: A-BUGS-14; http://bugs.sgul.
ac.uk/A-BUGS-14) and also ArrayExpress (accession number: A-
BUGS-14).
Feature extraction of intensity data was performed using
BlueFuse v3.5 (Cambridge BlueGnome). The microarray data
were median normalized and statistically analyzed using the
BioConductor package limma [73], correcting for multiple testing
by applying the Benjamini and Hochberg false discovery rate
method. Fully annotated microarray data has been deposited in
BmG@Sbase (accession number: E-BUGS-144; http://bugs.sgul.
ac.uk/E-BUGS-144) and also ArrayExpress (accession number: E-
BUGS-144).
RNA-seq experiments
RNA-seq sample preparation was conducted as described in
[42], with the following modifications. Cells were harvested from
10 mL Brain-Heart Infusion (BHI; Oxoid) cultures at an OD600 of
0.6 through centrifugation (2,594 g, 10 min) at room temperature,
then lysed by treatment with 30 mg mL21 lysosyme (Roche) at
room temperature for 15 min. Additionally, no effort was made to
deplete rRNA from the samples. Three independent paired
biological replicates were performed for both experiments and
have been submitted to the ENA under accession numbers
ERR015603, ERR015600 and ERR220392 for S. pneumoniae 99-
4038 and ERR015607, ERR015599 and ERR220393 for S.
pneumoniae 99-4039, respectively.
Mapping of RNA-seq data to the S. pneumoniae 99-4038 genome
was performed as described in [28]. Briefly, following mapping
with BWA [70], only uniquely mapping reads were used in the
calculation of read counts; these values were analysed using
DESeq [74]. These read counts were then used in the calculation
of RPKM values, which were adjusted for the length of the gene to
which unique read mapping was possible. This was ascertained
through simulating Illumina reads from the reference genome,
which were then self-mapped against the complete sequence using
the same algorithm as the RNA-seq mapping. This avoided
characterizing repetitive coding sequences as being transcribed at
artifactually low levels, as the density of read mapping would
otherwise seem abnormally low owing to the segments of the
feature across which no reads could be uniquely aligned.
Prediction of RNA secondary structure was performed using
RNAfold v1.7.2 from the Vienna package using default settings
[75].
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Phenotype microarray and antimicrobial sensitivity
analysis
Isolates 4038 and 4039 were compared using Omnilog
phenotype microarray plates PM9-20 [76]. Frozen stocks of S.
pneumoniae 4038 and 4039 were passaged twice on horse blood agar
plates (Oxoid) under microaerophilic conditions overnight in order
to prevent contamination of assays with glycerol. Colonies were
then scraped off plates using sterile cotton swabs and dispensed
into IF-0a solution (Biolog) at room temperature to a cell density
corresponding to 81% transmittance. For each Omnilog pheno-
type microarray plate used (PM9-20) [76], 880 mL of this cell
suspension was added to 10 mL IF-10b GP/GP solution (Biolog)
and 120 mL dye mix G (Biolog). This was then supplemented with
a 1 mL solution of 7.5 mM D-ribose (Sigma), 2 mM magnesium
chloride, 1 mM calcium chloride, 2 mM sodium pyrophosphate
(Sigma), 25 mM L-arginine (Sigma), 25 mM L-methionine (Sigma),
25 mM hypoxanthine (Sigma), 10 mM lipoamide (Sigma), 5 mM
nicotine adenine dinucleotide (Sigma), 0.25 mM riboflavin (Sigma),
0.005% by mass yeast extract (Fluka) and 0.005% by mass Tween
80 (Sigma). One hundred microliters of this mixture was dispensed
into each well on the assay plate. Plates were then allowed to
equilibrate in an anaerobic atmosphere (80% N2, 10% CO2, 10%
H2) for 5 min prior to being sealed in airtight bags and loaded into
the Omnilog machine (Biolog). Plates were scanned every 10 min
for 48 h while incubated at 37uC. Two paired replicates were
performed for the two isolates.
The data were exported from the Biolog File Manager, and
further analysis was conducted in R. The data was transformed in
to signal values as described previously [77]. The Bioconductor
package limma [73] was used to examine differential metabolism
between isolates. S. pneumoniae 99-4038 was used as a baseline from
which differences were calculated. Benjamini-Hochberg corrected
p values were used to determine statistical significance of
differences controlling for a false discovery rate of 5%.
Susceptibility to a variety of common antibiotics was also
determined using the Vitek 2 analyzer (bioMe´rieux) and the AST-
ST01 Streptococcus susceptibility card (bioMe´rieux) using a
starting inoculum density of 0.5 McFarland standard as measured
by densitometer (bioMe´rieux). Ciprofloxacin susceptibility was
determined using an E test (bioMe´rieux). An inoculum density of
0.5 McFarland standard was grown on Mueller Hinton Agar with
5% sheep blood (Oxoid) and incubated at 37uC in a 6% CO2
atmosphere for 20 h.
Mouse model of disease
Female outbred MF1 mice were purchased from Harlan Olac,
Bicester, UK. For pneumonia infection 9 week old mice were
lightly anaesthetised by inhalation of 2.5% v/v fluorothane. Viable
pneumococci at CFU/mL as indicated were then administered via
the nostrils in a 50 mL volume. Signs of disease were monitored
frequently until mice were deemed to have irreversibly succumbed
to the infection [78]; they were then humanely sacrificed through
exposure to carbon dioxide followed by cervical dislocation.
Cardiac blood was sampled immediately, and then skin and
muscles above the trachea were separated and the trachea was
dissected with microscissors. A fine tipped sterile Pasteur pipette
was inserted into each nostril in turn and 1 ml of tissue culture
grade PBS was pipetted through then collected from trachea.
Approximately 1 mL of nasopharyngeal lavage fluid (NPL) was
recovered from each mouse. No perfusion of the circulatory
system with PBS was performed as previous work has found the
contribution of blood borne bacteria to organ counts not to be
significant. Organs harvested for bacteriological investigation were
suspended in 2–5 mL PBS as appropriate and homogenized.
Viable bacteria in blood, NPL, and tissues were counted by plating
out serial dilutions on blood agar base number 2 plus 5% v/v
horse blood.
Construction and analysis of S. pneumoniae TIGR4PUS
The region upstream of patAB in S. pneumoniae 99-4038 and 99-
4039 was amplified through PCR using primers IntGL
(GCCTGCCACTTGTAGGTTTT) and IntGR (GATAGGG-
CAGAAGAGCATCC). The ,500 bp PCR products were each
purified through agarose gel electrophoresis using a QIAquick Gel
Extraction Kit (Qiagen) and then ligated into pGEM-T Easy
(Promega) using T4 ligase (Promega) in a 10 mL reaction volume,
according to manufacturer’s instructions. A 1 mL sample of this
reaction was then used to transform electrocompetent E. coli
TOP10 cells (Invitrogen) through electroporation with a 2.5 kV
pulse. These cells were then grown in 250 mL SOC medium
(Invitrogen), shaken at 37uC for 2 h. A 50 mL sample of this
culture was then spread on Luria broth (LB) agar plates
supplemented with 100 mg mL21 ampicillin (Sigma),
300 mg mL21 S-Gal (Sigma) and 30 mg mL21 isopropyl b-
thiogalactoside (Sigma). White colonies were then picked, grown
in LB supplemented with 100 mg mL21 ampicillin and stored. The
sequences of the plasmid inserts were then amplified by PCR and
checked through capillary sequencing. Both plasmids were then
extracted from their host E. coli using the QIAprep Spin Miniprep
Kit (Qiagen) and diluted to 25 mg mL21. These two stocks were
then used to transform three S. pneumoniae TIGR4 cultures in
parallel as described in [32]. After 2 h growth, a 50 mL sample of
each transformation reaction was used to inoculate either BHI or
BHI supplemented with 2 mg mL21 ciprofloxacin. Colonies were
then isolated from the S. pneumoniae TIGR4 culture transformed
with the region upstream of patAB from S. pneumoniae 99-4039 after
20 h growth in Brain-Heart Infusion (Oxoid) supplemented with
2 mg L21 ciprofloxacin. PCR amplification and sequencing of the
region upstream of patAB in three colonies from each of the three
transformation experiments revealed they all shared the PUS; one
of these was stored and designated S. pneumoniae TIGR4PUS. A
negative control transformation with the region upstream of patAB
from S. pneumoniae 99-4038, conducted in parallel, did not yield a
similarly high density of fluoroquinolone-resistant colonies.
Supporting Information
Figure S1 Distribution of homologous recombination lengths.
This histogram shows the lengths of the 79 detected recombina-
tions that occur outside of the annotated mobile genetic elements
in the OXC141 reference genome. These fit an exponential length
distribution with a rate parameter of 8.7161025 bp21 (95%
confidence interval of 7.1561025–1.1061024 bp21), which is
indicated on the plot by the red curve.
(PDF)
Figure S2 Analysis of sequence using BRATnextgen. (A) The
phylogeny of the lineage, and (B) the annotation of the reference
genome, are displayed as in Figure 1. (C) The coloured bars
underneath the annotation indicate an independent analysis of
sequence exchange within the lineage, performed using BRAT-
nextgen. Each of the bars represents the cluster to which the
sequence belongs at different points along the genome; the key
indicates the groups to which the colours correspond. The analysis
confirms that there is little sequence exchange within clade I, in
which the sequence almost entirely belongs to group 1. The only
significant recombination is a block from the ‘outgroup’ (i.e. a
genotype outside the collection) representing the acquisition of
prophage wBHN167, in agreement with the analysis displayed in
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Figure 1. No substantial exchange of sequence between clades is
observed anywhere in the collection, with the only large
recombination detected being an apparent exchange of sequence
within clade II.
(PDF)
Figure S3 Heatmap showing the distribution of prophage
sequences between serotype 3 isolates. (A) All available S.
pneumoniae prophage genomes, including wOXC141, wBHN167
(ENA accession code HF563658) and w072838 derived from
genomes sequenced as part of this study, are clustered and
grouped based on gene content as described in [29]. The
alternating orange and brown bars underneath the clustering
indicate the extent of each prophage. (B) The maximum
likelihood phylogeny of the serotype 3 isolates is displayed as
in Figure 1. (C) A heatmap of Illumina sequence read coverage
of the prophage sequences per million reads mapped is
displayed for each taxon. Blue indicates low coverage, and red
indicates high coverage.
(PDF)
Figure S4 Activity of prophage sequences. (A) Annotation of
prophage wOXC141 and the flanking genomic regions. The
modular organisation typical of pneumococcal prophage is
marked relative to the viral sequence. (B) Mapping of Illumina
genome sequencing data from isolates (i) BHN640 (ii) BHN035
and (iii) BHN598, phylogenetically disparate within clade I. The
two- to three-fold increased coverage of wOXC141 suggests it is
actively replicating. (C) Prophage transcription. The RNA-seq
data from (i) 4038 and (ii) 4039 indicate that in some cells, the
lysogeny module is active, keeping the prophage dormant, while in
others, the modules required for replication and host cell lysis are
expressed.
(PDF)
Figure S5 Histogram showing the genome-wide levels of protein
CDS expression. The distribution of coding sequence read counts
per kilobase length per million reads mapped (RPKM) values, on a
base 10 logarithmic scale, is shown as a histogram. This shows the
continuum of expression levels observed in the data, with no
evidence of any set of discrete expression levels.
(PDF)
Figure S6 Boxplots showing the mean level of transcription of
CDSs, as grouped according to functional annotation. This shows
the group of proteins most highly transcribed, on average, are
those involved in the core pathways of energy metabolism and
nucleic acid and protein synthesis. Pseudogenes tend to exhibit
lower levels of transcription than functional genes.
(PDF)
Figure S7 Scatterplot relating the level of gene expression to the
relative amount of antisense transcription according to gene
category. Each point plots the base 10 logarithm of the level of
sense transcription against the base 10 logarithm of the ratio of
sense to antisense transcription. Each point is coloured according
to its function as in Figure S6, with the exception of the
pathogenicity, adaptation and chaperone proteins, which are
coloured black. Two cases are evident of genes with putative
functional information being transcribed in the antisense direction
at a high level. One is the comCDE operon, which encodes the
competence stimulating peptide precursor and its cognate
receptor, and the other is the SP4038_7830-SP4038_07880
operon, encoding a restriction modification system. Both are
marked on the plot.
(PDF)
Figure S8 Construction of S. pneumoniae TIGR4PUS. A sample of
S. pneumoniae TIGR4 was transformed with the region upstream of
patAB from either (A) and (C) S. pneumoniae 99-4038 or (B) and (D)
S. pneumoniae 99-4039. The transformed cultures were then grown
in (A) and (B) BHI or (C) and (D) BHI supplemented with
2 mg mL21 ciprofloxacin. The bars show the mean optical density
at 600 nm after 20 h growth at 37uC, with the error bars showing
one standard error of the mean. S. pneumoniae TIGR4PUS was
isolated after culturing isolates from (D) on horse blood agar plates
supplemented with 2 mg mL21 ciprofloxacin.
(PDF)
Figure S9 Further in vivo experiments comparing isolates S.
pneumoniae TIGR4 and TIGR4PUS, where the latter has had the
PUS introduced in vitro. The outcomes displayed are: (A) survival
curves, (B) level of bacteraemia (C) counts of the two isolates in
different organs following intraperitoneal inoculation with 104 cfu.
In Figure 4, it is shown that S. pneumoniae 4039 kills all mice
significantly quicker than S. pneumoniae 4038, although there was
not a significant difference between S. pneumoniae TIGR4 and
TIGR4PUS by the same metric. S. pneumoniae TIGR4PUS is found
at a significantly higher density in the mouse brain relative to
TIGR4.
(PDF)
Figure S10 Root-to-tip plot showing genetic divergence of clade
I over time. For the 66 samples within clade I for which a precise
year of isolation was available, this value was plotted against the
distance of each isolate from the root of the clade, as according to
the maximum likelihood tree displayed in Figure 1. This reveals a
weak positive correlation that suggests that the clade originated
around 1946.
(PDF)
Table S1 Epidemiological data and ENA accession codes for all
sequences used in the phylogenomic analysis.
(XLSX)
Table S2 Polymorphisms distinguishing S. pneumoniae 99-4038
and 99-4039.
(DOCX)
Table S3 Significant differences in expression patterns between
S. pneumoniae 4038 and 4039 detected using a microarray based on
the S. pneumoniae TIGR4 and R6 genomes. Statistical analysis was
performed using limma. The displayed p value is adjusted to reflect
correction for multiple testing using the Benjamini-Hochberg
method.
(DOCX)
Table S4 Significant differences in expression patterns between
S. pneumoniae 4038 and 4039 detected using a RNA-seq. Statistical
analysis was performed using DESeq. The displayed p value is
adjusted to reflect correction for multiple testing using the
Benjamini-Hochberg method.
(DOCX)
Table S5 Results of the Omnilog phenotype microarray assay.
This table lists the compounds found to result in significantly
higher respiration in 4039 relative to 4038. Each compound was
tested at four different concentrations; that concentration at
which a significant difference was observed is indicated by a
number, with one being the lowest concentration and four being
the highest. The displayed p value is adjusted to reflect
correction for multiple testing using the Benjamini-Hochberg
method.
(DOCX)
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Table S6 Susceptibility of isolates S. pneumoniae 99-4038, 99-
4039, TIGR4 and TIGR4PUS to common antibiotics. Minimum
inhibitory concentrations (MICs) were determined either used the
Vitek 2 or E test methods.
(DOCX)
Table S7 Significant differences in expression patterns between
S. pneumoniae TIGR4 and the modified strain carrying the PUS
(TIGR4PUS), detected using a microarray based on the S.
pneumoniae TIGR4 genome. Statistical analysis was performed
using limma. The displayed p value is adjusted to reflect multiple
testing using the Benjamini-Hochberg method.
(DOCX)
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